VIVUS to Present at Wachovia Securities 2007 Healthcare ConferenceDrug Newswire (press release), CT - 7 hours ago… Testosterone MDTS(R), for which a Phase 2 study has been completed for the treatment of Hypoactive Sexual Desire Disorder (HSDD); EvaMist(TM), …
Read full story
VIVUS to Present at Wachovia Securities 2007 Healthcare ConferenceGenetic Engineering News (press release), NY - 11 hours ago… Testosterone MDTS(R), for which a Phase 2 study has been completed for the treatment of Hypoactive Sexual Desire Disorder (HSDD); EvaMist(TM), …
Read full story
VIVUS to Present at Wachovia Securities 2007 Healthcare ConferencePR Newswire (press release), NY - 16 hours ago… Testosterone MDTS(R), for which a Phase 2 study has been completed for the treatment of Hypoactive Sexual Desire Disorder (HSDD); EvaMist(TM), …
Read full story
VIVUS to Present at 2nd Annual Menopause Pharmacotherapeutic …PharmaLive.com (press release), PA - Jan 16, 2007… Testosterone MDTS(R), for which a Phase 2 study has been completed for the treatment of Hypoactive Sexual Desire Disorder (HSDD); EvaMist(TM), …
Read full story
VIVUS to Present at 2nd Annual Menopause Pharmacotherapeutic …Drug Newswire (press release), CT - 7 hours ago… Testosterone MDTS(R), for which a Phase 2 study has been completed for the treatment of Hypoactive Sexual Desire Disorder (HSDD); EvaMist(TM), …
Read full story
VIVUS to Present at 2nd Annual Menopause Pharmacotherapeutic …PR Newswire (press release), NY - 11 hours ago… Testosterone MDTS(R), for which a Phase 2 study has been completed for the treatment of Hypoactive Sexual Desire Disorder (HSDD); EvaMist(TM), …
Read full story
Clinical Trials Update: Jan. 10, 2007Forbes, NY - 7 hours agoThis study will evaluate whether an investigational medication is safe and effective in treating hypoactive sexual desire disorder, when taken orally either …
Read full story
BioSante Pharmaceuticals Initiates Phase III Study of LibiGel …PharmaLive.com (press release), PA - Dec 28, 2006… into Phase III pivotal studies of women with low sexual desire, the largest component of FSD, also known as Hypoactive Sexual Desire Disorder (HSDD)," said …
Read full story